Effect of GLP-1 receptor agonists on postprandial lipaemia: commentary on a review article
Authors:
Peter Novodvorský 1,2,3
Authors place of work:
Metabolické centrum, s. r. o., Trenčín, Slovensko
1; Cetrum diabetologie, IKEM, Praha, Česká Republika
2; Department of Oncology & Metabolism, University of Sheffield, Sheffield, UK
3
Published in the journal:
Diab Obez 2022; 22(43): 52-53
Category:
News
Zdroje
1. Novodvorsky P, Haluzik M. The Effect of GLP-1 Receptor Agonists on Postprandial Lipaemia. Curr Atheroscler Rep 2022; 24(1): 13–21. Dostupné z DOI: <http://doi: 10.1007/s11883–022–00982–3>.
Štítky
Diabetology ObesitologyČlánok vyšiel v časopise
Diabetes and obesity
2022 Číslo 43
Najčítanejšie v tomto čísle
- Treatment with biosimilar insulin in routine clinical practice in Slovakia: case reports
- Cardiovascular effect of GLP-1 receptor agonists: meta-analyses suggest a class effect
- Relationship of glycemic variability and diabetes risk factors in pregnant women
- Use of SGLT2 inhibitors in type 2 diabetics at different stages of the cardiovascular continuum